TrialHuman vaccines & immunotherapeutics2024

Lot-to-lot consistency, immunogenicity, and safety of the Ad26.ZEBOV, MVA-BN-Filo Ebola virus vaccine regimen: A phase 3, randomized, double-blind, placebo-controlled trial.

Neil Goldstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.